David B. Samadi

David B. Samadi is an American urologist, a Newsmax contributor, and the former Chairman of Urology and Chief of Robotic Surgery at Lenox Hill Hospital.

David B. Samadi
Born
Iran
NationalityAmerican
EducationB.S. Stony Brook University
M.D. SUNY Stony Brook School of Medicine
Henri Mondor - Creteil, France
Memorial Sloan Kettering Cancer Center
OccupationUrologist

Former Chairman of Urology Dept. at Lenox Hill Hospital

Newsmax Medical Contributor
Websitesamadimd.com

Biography

Born and raised in the Persian Jewish community of Iran, at age 15 Samadi and his younger brother left in 1979 after the Iranian Revolution. They continued their education in Belgium and the UK before coming to the United States where Samadi completed high school in Roslyn, New York. He attended Stony Brook University and earned his degree in biochemistry. He earned his M.D from S.U.N.Y., Stony Brook School of Medicine, Stony Brook, New York in 1994, and completed his postgraduate training in urology at Montefiore Medical Center and in urology at Albert Einstein College of Medicine in 1996 and Montefiore Medical Center in 2000. He completed an oncology fellowship in urology at Memorial Sloan Kettering Cancer Center in 2001 and a robotic radical prostatectomy fellowship at Henri Mondor Hospital Creteil in France under the mentorship of Professor Claude Abbou in 2002.[1]

Career

He first practiced at Columbia Presbyterian Hospital, then joined the faculty of Mt. Sinai School of Medicine in 2007 where he became the Vice Chair of the Department of Urology, and the Chief of Robotics and Minimally Invasive Surgery.[2] In 2012, he was the highest paid doctor in New York City, earning $7.6 million.[3]

He invented the Samadi Modified Advanced Robotic Treatment for prostate cancer surgeries. The technique was designed to replace open surgery with a minimally invasive alternative using the da Vinci Surgical System.[4]

In November 2019, Lenox Hill agreed to pay $12.3 million to settle a Medicare fraud lawsuit brought because Samadi performed multiple surgeries at the same time, leaving patients unsupervised by a urologist when he left one operating room for another; billing for unnecessary procedures; and inadequately supervised residents. The suit was the result of an investigation by the United States Attorney for the Southern District of New York, Geoffrey Berman, who characterized the approach as "assembly line medicine" in violation of Medicare and hospital regulations.[5]

Patients were distressed to learn that Samadi was not actually performing their surgical procedures and was often not in the operating room, according to an investigation by the Boston Globe.[6][7]

In June 2020, He joined conservative news outlet Newsmax as a medical contributor.[8]

He is currently director of men's health at St. Francis Hospital in Flower Hill, New York.[9]

References

  1. Gupte, Pranay (January 17, 2006). "Doctor Discusses Plans To Perform Tele-Surgery". The New York Sun.
  2. Fern Siman for Jewish Voice NY. July 10, 2013. Sitting on Top of the World with Dr. David Samadi
  3. Melissa Klein for the NY Post. April 13, 2014 City’s hospital specialists are raking in millions of dollars
  4. Ferguson, Michael (October 13, 2014). "Experience Matters: David B. Samadi, MD — Advancing Robotic Prostate Surgeries Worldwide". MD News.
  5. Saul, Emily (November 8, 2019). "Lenox Hill Hospital will shell out $12.3M for submitting fraudulent claims to Medicare". New York Post. Retrieved November 9, 2019.
  6. "Star surgeon is scrutinized on concurrent procedures - The Boston Globe". BostonGlobe.com. Retrieved November 9, 2019.
  7. Saltzman, Jonathan (October 5, 2017). "Federal prosecutors launch investigation of prominent surgeon who double-booked operations". The Boston Globe. Retrieved October 16, 2023 via Boston.com.
  8. Eggerton, John (June 8, 2020). "Samadi Named Newsmax Medical Contributor". Multichannel News. Retrieved November 29, 2020.
  9. "Men's Health". St. Francis Hospital. Retrieved July 5, 2020.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.